Global Virus Like Particles Market Study 2015-2025, by Segment (Adeno-Associated Virus, HIV, Hepatitis B Virus), by Market (Vaccines, Mycoviruses, Virus Research), by Company (GlaxoSmithKline, Merck, Novavax)

November 2018 | 79 pages | ID: GD44D48AE99EN
99Strategy

Abstracts

Snapshot

The global Virus Like Particles market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Adeno-Associated Virus
• HIV
• Hepatitis B Virus
• Hepatitis C Virus
• Others

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Vaccines
• Mycoviruses
• Virus Research
• Therapeutic and Imaging Agents
• Others

Company Coverage (Sales data, Main Products & Services etc.):

• GlaxoSmithKline
• Merck
• Novavax
• Takeda
• Medicago
• MedImmune
• TechnoVax
• Agilvax
• Allergy Therapeutics
• Serum Institute of India
• GeoVax Labs
• Cytos Biotechnology
• ANGANY Genetics
• CPL Biologicals
• Xiamen Innovax Biotech

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 Virus Like Particles Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 VIRUS LIKE PARTICLES MARKET BY TYPE

2.1 By Type
  2.1.1 Adeno-Associated Virus
  2.1.2 HIV
  2.1.3 Hepatitis B Virus
  2.1.4 Hepatitis C Virus
  2.1.5 Others
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Vaccines
  3.1.2 Mycoviruses
  3.1.3 Virus Research
  3.1.4 Therapeutic and Imaging Agents
  3.1.5 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 GlaxoSmithKline (Company Profile, Sales Data etc.)
5.2 Merck (Company Profile, Sales Data etc.)
5.3 Novavax (Company Profile, Sales Data etc.)
5.4 Takeda (Company Profile, Sales Data etc.)
5.5 Medicago (Company Profile, Sales Data etc.)
5.6 MedImmune (Company Profile, Sales Data etc.)
5.7 TechnoVax (Company Profile, Sales Data etc.)
5.8 Agilvax (Company Profile, Sales Data etc.)
5.9 Allergy Therapeutics (Company Profile, Sales Data etc.)
5.10 Serum Institute of India (Company Profile, Sales Data etc.)
5.11 GeoVax Labs (Company Profile, Sales Data etc.)
5.12 Cytos Biotechnology (Company Profile, Sales Data etc.)
5.13 ANGANY Genetics (Company Profile, Sales Data etc.)
5.14 CPL Biologicals (Company Profile, Sales Data etc.)
5.15 Xiamen Innovax Biotech (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

Table GLOBAL VIRUS LIKE PARTICLES MARKET 2015-2018, BY TYPE, IN USD MILLION
Table Global Virus Like Particles Market 2015-2018, by Type, in Volume
Table Global Virus Like Particles Market Forecast 2019-2025, by Type, in USD Million
Table Global Virus Like Particles Market Forecast 2019-2025, by Type, in Volume
Table GlaxoSmithKline Overview List
Table Virus Like Particles Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Virus Like Particles Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novavax Overview List
Table Virus Like Particles Business Operation of Novavax (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Overview List
Table Virus Like Particles Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Medicago Overview List
Table Virus Like Particles Business Operation of Medicago (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedImmune Overview List
Table Virus Like Particles Business Operation of MedImmune (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table TechnoVax Overview List
Table Virus Like Particles Business Operation of TechnoVax (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Agilvax Overview List
Table Virus Like Particles Business Operation of Agilvax (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergy Therapeutics Overview List
Table Virus Like Particles Business Operation of Allergy Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Serum Institute of India Overview List
Table Virus Like Particles Business Operation of Serum Institute of India (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GeoVax Labs Overview List
Table Virus Like Particles Business Operation of GeoVax Labs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cytos Biotechnology Overview List
Table Virus Like Particles Business Operation of Cytos Biotechnology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ANGANY Genetics Overview List
Table Virus Like Particles Business Operation of ANGANY Genetics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CPL Biologicals Overview List
Table Virus Like Particles Business Operation of CPL Biologicals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Xiamen Innovax Biotech Overview List
Table Virus Like Particles Business Operation of Xiamen Innovax Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global Virus Like Particles Market Growth 2015-2018, by Type, in USD Million
Figure Global Virus Like Particles Market Growth 2015-2018, by Type, in Volume